Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Other Non Operating Income (2018 - 2025)

Historic Other Non Operating Income for Fortress Biotech (FBIO) over the last 7 years, with Q3 2025 value amounting to $17.7 million.

  • Fortress Biotech's Other Non Operating Income rose 155004.67% to $17.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year increase of 8001818.18%. This contributed to the annual value of $1.3 million for FY2024, which is 13873.05% up from last year.
  • As of Q3 2025, Fortress Biotech's Other Non Operating Income stood at $17.7 million, which was up 155004.67% from -$62000.0 recorded in Q2 2025.
  • Fortress Biotech's Other Non Operating Income's 5-year high stood at $17.7 million during Q3 2025, with a 5-year trough of -$1.4 million in Q4 2023.
  • For the 4-year period, Fortress Biotech's Other Non Operating Income averaged around $1.5 million, with its median value being $304000.0 (2023).
  • In the last 5 years, Fortress Biotech's Other Non Operating Income crashed by 33880.07% in 2023 and then soared by 155004.67% in 2025.
  • Quarter analysis of 4 years shows Fortress Biotech's Other Non Operating Income stood at $567000.0 in 2022, then tumbled by 338.8% to -$1.4 million in 2023, then soared by 98.82% to -$16000.0 in 2024, then surged by 110550.0% to $17.7 million in 2025.
  • Its Other Non Operating Income stands at $17.7 million for Q3 2025, versus -$62000.0 for Q2 2025 and -$12000.0 for Q1 2025.